Best of BS Opinion: Herbs need good marketing, second Covid-19 wave & more

Here are the best of Business Standard's opinion pieces for Monday

Exports, imports, economy, coronavirus, covid-19, vaccine
Illustration: Ajay Mohanty
Kanika Datta New Delhi
1 min read Last Updated : May 17 2021 | 6:30 AM IST
There is a health catastrophe playing out around us but the gloom about the Indian economy is overstated and it’s time to look to the future, writes Ajay Shah. The present holds clues to the way forward for decision makers in firms: in vaccination and in exports. He explains why here.
 
In other views today:

Tamal Bandyopadhyay suggests that there’s a simple solution to the chronic underperformance of asset reconstruction companies. Break the cosy relationship between banks and ARC, he says. Read his analysis here
 
Surinder Sud says the mostly unorganised, unregulated, and non-transparent nature of the business of cultivation of herbs is hampering the development of a more lucrative market opportunity. Read it here
 
The top edit examines Q4 corporate results and warns that the second wave of the pandemic could derail recovery. Read it here
 
The second edit says till vaccine supply improves, India must also focus on a flexible and supportive medical infrastructure. Read it here
 

QUOTE OF THE DAY

“We are looking to press a pause button on some of our non-priority spending”

Government official to Reuters

Topics :CoronavirusBS OpinionCurated ContentVaccinationVaccineIndian exportsIndian EconomyIndian companiesIndia IncQ4 Resultscorporate earningsAsset reconstruction companies ARCsHerbs

Next Story